The U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. The Moderna COVID-19 Vaccine, Bivalent is authorized for administration at least two months following completion of primary or booster vaccination in children down to six years of age.
- Read more about FDA authorizes Moderna and Pfizer BioNTech vaccines for child booster
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/fda-authorizes-moderna-and-pfizer-biontech-vaccines-for-child-booster
No comments:
Post a Comment